L. M. Hartmann
University of Duisburg-Essen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by L. M. Hartmann.
Critical Reviews in Toxicology | 2004
Elke Dopp; L. M. Hartmann; A.-M. Florea; A.W. Rettenmeier; Alfred V. Hirner
ABSTRACT The biochemical modification of the metals and metalloids mercury, tin, arsenic, antimony, bismuth, selenium, and tellurium via formation of volatile metal hydrides and alkylated species (volatile and involatile) performs a fundamental role in determining the environmental processing of these elements. In most instances, the formation of such species increases the environmental mobility of the element, and can result in bioaccumulation in lipophilic environments. While inorganic forms of most of these compounds are well characterized (e.g., arsenic, mercury) and some of them exhibit low toxicity (e.g., tin, bismuth), the more lipid-soluble organometals can be highly toxic. Methylmercury poisoning (e.g., Minamata disease) and tumor development in rats after exposure to dimethylarsinic acid or tributyltin oxide are just some examples. Data on the genotoxicity (and the neurotoxicity) as well as the mechanisms of cellular action of organometal(loid) compounds are, however, scarce. Many studies have shown that the production of such organometal(loid) species is possible and likely whenever anaerobic conditions (at least on a microscale) are combined with available metal(loid)s and methyl donors in the presence of suitable organisms. Such anaerobic conditions can exist within natural environments (e.g., wetlands, pond sediments) as well as within anthropogenic environmental systems (e.g., waste disposal sites and sewage treatments plants). Some methylation can also take place under aerobic conditions. This article gives an overview about the environmental distribution of organometal(loid) compounds and the potential hazardous effects on animal and human health. Genotoxic effects in vivo and in vitro in particular are discussed.
Drug Metabolism and Disposition | 2008
Elke Dopp; Ursula von Recklinghausen; L. M. Hartmann; Inga Stueckradt; Ilona Pollok; S. Rabieh; Liping Hao; Andreas K. Nussler; Cindy Katier; Alfred V. Hirner; A.W. Rettenmeier
Epidemiological studies have indicated that exposure of humans to inorganic arsenic in drinking water is associated with the occurrence of bladder cancer. The mechanisms by which arsenic induces this malignancy are still uncertain; however, arsenic metabolites are suspected to play a pivotal role. The aim of the present study was the investigation of uptake capabilities of human urothelial cells (UROtsa) compared with primary human hepatocytes (phH) as well as the intracellular distribution of the arsenic species. Additionally, we were interested in the cyto- and genotoxic potential (comet assay, radical generation) of the different arsenic compounds in these two cell types. Our results show that UROtsa cells accumulate higher amounts of the arsenic species than the phH. Differential centrifugation revealed that the arsenic compounds are preferentially distributed into nuclei and ribosomes. After 24-h exposure, arsenic is mainly found in the ribosomes of UROtsa cells and in the nuclei and mitochondria of phH. In contrast to the pentavalent arsenic species, the trivalent species induced a 4- to 5-fold increase of DNA damage in hepatocytes. Radical generation, measured by thiobarbituric acid reactive substances, was more pronounced in hepatocytes than in urothelial cells. In summary, the uptake of arsenic compounds appears to be highly dependent upon cell type and arsenic species. The nonmethylating urothelial cells accumulate higher amounts of arsenic species than the methylating hepatocytes. However, cyto- and genotoxic effects are more distinct in hepatocytes. Further studies are needed to define the implications of the observed accumulation in cellular organelles for the carcinogenic activity of arsenic.
Chemical Research in Toxicology | 2008
U. von Recklinghausen; L. M. Hartmann; S. Rabieh; Jörg Hippler; Alfred V. Hirner; A.W. Rettenmeier; Elke Dopp
Bismuth compounds are widely used in industrial processes and products. In medicine, bismuth salts have been applied in combination with antibiotics for the treatment of Helicobacter pylori infections, for the prevention of diarrhea, and in radioimmunotherapy. In the environment, bismuth ions can be biotransformed to the volatile bismuth compound trimethylbismuth (Me3Bi) by methanobacteria. Preliminary in-house studies have indicated that bismuth ions are methylated in the human colon by intestinal microflora following ingestion of bismuth-containing salts. Information concerning cyto- and genotoxicity of these biomethylated products is limited. In the present study, we investigated the cellular uptake of an organic bismuth compound [monomethylbismuth(III), MeBi(III)] and two other bismuth compounds [bismuth citrate (Bi-Cit) and bismuth glutathione (Bi-GS)] in human hepatocytes, lymphocytes, and erythrocytes using ICP-MS. We also analyzed the cyto- and genotoxic effects of these compounds to investigate their toxic potential. Our results show that the methylbismuth compound was better taken up by the cells than Bi-Cit and Bi-GS. All intracellularly detected bismuth compounds were located in the cytosol of the cells. MeBi(III) was best taken up by erythrocytes (36%), followed by lymphocytes (17%) and hepatocytes (0.04%). Erythrocytes and hepatocytes were more susceptible to MeBi(III) exposure than lymphocytes. Cytotoxic effects of MeBi(III) were detectable in erythrocytes at concentrations >4 microM, in hepatocytes at >130 microM, and in lymphocytes at >430 microM after 24 h of exposure. Cytotoxic effects for Bi-Cit and Bi-GS were much lower or not detectable in the used cell lines up to a tested concentration of 500 microM. Exposure of lymphocytes to MeBi(III) (250 microM for 1 h and 25 microM/50 microM for 24 h) resulted in significantly increased frequencies of chromosomal aberrations (CA) and sister chromatid exchanges (SCE), whereas Bi-Cit and Bi-GS induced neither CA nor SCE. Our study also showed an intracellular production of free radicals caused by MeBi(III) in hepatocytes but not in lymphocytes. These data suggest that biomethylation of bismuth ions by the intestinal microflora of the human colon leads to an increase in the toxicity of the primary bismuth salt.
Drug Metabolism and Disposition | 2009
Jens Boertz; L. M. Hartmann; Margareta Sulkowski; Joerg Hippler; Frank Mosel; Roland A. Diaz-Bone; Klaus Michalke; A.W. Rettenmeier; Alfred V. Hirner
Biological methylation and hydride formation of metals and metalloids are ubiquitous environmental processes that can lead to the formation of chemical species with significantly increased mobility and toxicity. Whereas much is known about the interaction of metal(loid)s with microorganisms in environmental settings, little information has been gathered on respective processes inside the human body as yet. Here, we studied the biotransformation and excretion of bismuth after ingestion of colloidal bismuth subcitrate (215 mg of bismuth) to 20 male human volunteers. Bismuth absorption in the stomach and upper intestine was very low, as evidenced by the small quantity of bismuth eliminated via the renal route. Total bismuth concentrations in blood increased rapidly in the first hour after ingestion. Most of the ingested bismuth was excreted via feces during the study period. Trace levels of the metabolite trimethylbismuth [(CH3)3Bi] were detected via low temperaturegas chromatography/inductively coupled plasma-mass spectrometry in blood samples and in exhaled air samples. Concentrations were in the range of up to 2.50 pg/ml (blood) and 0.8 to 458 ng/m3 (exhaled air), with high interindividual variation being observed. Elimination routes of bismuth were exhaled air (up to 0.03‰), urine (0.03–1.2%), and feces. The site of (CH3)3Bi production could not be identified in the present study, but the intestinal microflora seems to be involved in this biotransformation if accompanying ex vivo studies are taken into consideration.
Archive | 2004
Alfred V. Hirner; L. M. Hartmann; Jörg Hippler; J. Kresimon; J. Koesters; Klaus Michalke; Martin Sulkowski; A.W. Rettenmeier
Biomethylation of metals and metalloids is a well-known process ubiquitously occurring in the environment, which leads to the formation of chemical species with significantly higher mobility and altered toxicology. There are only a few historical reports, e.g. about “bismuth breath” or “Gosio gas” dealing with the association of humans with methylated metal(loid)s. Although the toxicity of the latter [later identified as trimethyl arsine (Challenger 1945)] has not been conclusively demonstrated, this gas produced by fungi in wet wallpaper was considered to be the reason for the illness of people living there (Gosio 1897). Amongst other observations, dimethyltellurium in “bismuth breath” of mine workers, dimethylselenium in the upper ng/m3 range in human breath, as well as the detection of at least twenty-two different organometal(loid) species in human urine are indications for the methylation of metal(loid)s occurring in humans (Cai et al. 1995; Feldmann et al. 1996; Kresimon et al. 2001).
Toxicology and Applied Pharmacology | 2004
Elke Dopp; L. M. Hartmann; A.-M. Florea; U. von Recklinghausen; R. Pieper; B. Shokouhi; A.W. Rettenmeier; Alfred V. Hirner; Günter Obe
Toxicological Sciences | 2005
Elke Dopp; L. M. Hartmann; U. von Recklinghausen; A.-M. Florea; S. Rabieh; U. Zimmermann; B. Shokouhi; Santosh Yadav; Alfred V. Hirner; A.W. Rettenmeier
Toxicology | 2007
Elke Dopp; L. M. Hartmann; U. von Recklinghausen; A.-M. Florea; S. Rabieh; B. Shokouhi; Alfred V. Hirner; Günter Obe; A.W. Rettenmeier
Toxicology and Applied Pharmacology | 2007
Katharina Krüger; Hendrik Repges; Jörg Hippler; L. M. Hartmann; Alfred V. Hirner; Heidrun Straub; Norbert Binding; Ulrich Mußhoff
Archives of Toxicology | 2006
Katharina Krüger; Janina Gruner; Michael Madeja; L. M. Hartmann; Alfred V. Hirner; Norbert Binding; Ulrich Mußhoff